MedTrace Logo

Magnesium Sulphate and Lidocaine in Hemodynamic Changes and Cortisol Levels

NCT06516861 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2024-07-24

No results posted yet for this study

Summary

The sample was randomly divided into 3 groups consisting of patients who received Magnesium Sulfate 30 mg/Kg, Lidocaine 1.5 mg/Kg, and Control. These groups will be checked for hemodynamic changes and cortisol values.

Conditions

  • Intubation Complication

Interventions

DRUG

Magnesium Sulfate 20 MG/ML

Administered intravenously with a dose of 30 mg/kg

DRUG

Lidocaine IV

Administered intravenously with a dose of 1.5mg/Kg

DRUG

saline solution

Administered intravenously with 20 ml

Sponsors & Collaborators

  • Universitas Sumatera Utara

    collaborator OTHER

  • Arsil Radiansyah

    lead OTHER

Principal Investigators

  • Rr Sinta Irina, MD · Universitas Sumatera Utara

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-01-31
Primary Completion
2024-02-01
Completion
2024-03-01

Countries

  • Indonesia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06516861 on ClinicalTrials.gov